The latest mergers, acquisitions, and strategic partnerships transforming the cannabis sector.
Curaleaf Holding’s months-long hostile takeover bid for Aurora Cannabis has been blown out of the water by Organigram Global, which has now tabled a significantly higher bid.
This article was written by Sean McLean, CEO & Co-Founder, Peregrine Precision Systems, and originally published here.
Curaleaf Holdings’s takeover bid for its Canadian rival Aurora Cannabis has evolved into a public spat between the two cannabis giants over whose financial projections are honest, who would actually control the proposed new entity, and whether the current bid can even close on its own terms.
As Aurora faces down an unsolicited takeover bid from one of the world’s largest cannabis companies, it has continued to expand its reach in what it sees as the markets of the near future.
Curaleaf Holdings has pushed ahead with its unexpected and unsolicited acquisition campaign of Aurora Cannabis and has now submitted an official bid for its Canadian rival.
Curaleaf Holdings (CURA) announced this week that it intends to launch an unsolicited take-over bid of its rival Aurora Cannabis (ACB) in what would mark one of the most consequential consolidation moves in industry history.
Argent Biopharma’s (RGT) flagship CannEpil cannabis drug is set to pivot into the veterinary market, just weeks after it signed away the commercial rights in exchange for debt relief.
Argent BioPharma (RGT), formerly MGC Pharmaceuticals, has sold the global commercialisation rights of its leading epilepsy drug, CannEpil, in order to clear a sizable chunk of its debt.
Tilray Brands (TLRY) has acquired HelloMD Corporation’s Canadian medical cannabis assets through a court-supervised insolvency sale, with court approval granted on 29 June 2026.
